As Synageva is taken over by Alexion, its entry to the domestic market become vague
The American pharmaceutical company, Synageva, has encountered difficulties in expansion to the Korean market.
According to the industry concerned on the 24th, a pharmaceutical companies specializing in rare and incurable diseases, Synageva Biopharma, was working on a process to launch its domes...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
